Siebels I: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 16: | Line 16: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
==Participated at== | |||
::::* [[IOC23|IOC23 Schroecken AT]] | |||
Latest revision as of 14:30, 12 February 2018
| Name | Siebels Ilka, |
|---|---|
| Institution | |
| Address | Uniklinik Frankfurt am Main
Molekulare Bioenergetik AG Prof. Brandt Haus 26 / 4. OG Theodor Stern Kai 7 60590 Frankfurt am Main, Germany, |
| City | |
| State/Province | |
| Country | |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | DE Frankfurt Droese S, NL Nijmegen Brandt U |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Siebels 2013 Biochim Biophys Acta | 2013 | Siebels I, Dröse S (2013) Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates. Biochim Biophys Acta 1827:1156-64. |
